RICT 2018 - Interfacing Chemical Biology and Drug Discovery

Published on 20.06.2018

July 4-6, 2018

July 4-6, 2018

The congress will be devoted to “Interfacing Chemical Biology and Drug Discovery” and the main topics will be:

  • New opportunities for metabolic and cardiovascular diseases
  • New breakthroughs in GPCR structure, function and their impact on drug discovery
  • New modalities for challenging targets in drug discovery
  • Chemical biology in drug discovery: visualizing biological processes
  • Tackling challenges in drug delivery and formulation
  • Case studies: from target validation to novel drugs (all therapeutic areas included)

Iris Biotech GmbH is going to be there as exhibitor

We are looking forward to meet you at our booth no. 6.

Link: https://www.rict2018.org/